Results 121 to 130 of about 34,592 (189)

Different SARS‐CoV‐2 Subvariants and Coagulation Markers Trend: A Retrospective Multicentric Study From Iranian Network for Research in Viral Diseases (INRVD)

open access: yesHealth Science Reports, Volume 9, Issue 4, April 2026.
ABSTRACT Background and Aims This study aims to examine the prevalence and progression of coagulation disorders in adult COVID‐19 patients and evaluate the effect of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) on coagulation markers. Methods This retrospective study included 1885 hospitalized COVID‐19 patients, aged 20 to over 90 years,
Alireza Razavi   +100 more
wiley   +1 more source

Exploring Erythrina flavonoids as potential SARS-CoV-2 RdRp inhibitors through virtual screening, in silico ADMET evaluation, and molecular dynamics simulation studies

open access: yesScientific Reports
The COVID-19 pandemic, caused by SARS-CoV-2, has intensified the search for effective antiviral agents. This study investigates the inhibitory potential of 473 flavonoids from the genus Erythrina against the key enzyme of SARS-CoV-2, RNA-dependent RNA ...
Tati Herlina   +6 more
doaj   +1 more source

Dual‐vector transmission of a pepper polerovirus: a plant virus is transmitted by both aphids and the supervector whitefly Bemisia tabaci

open access: yes
New Phytologist, Volume 250, Issue 3, Page 1370-1377, May 2026.
José Natividad Jaén‐Sanjur   +3 more
wiley   +1 more source

Novel analogues of a nonnucleoside SARS-CoV-2 RdRp inhibitor as potential antivirotics

open access: yesBeilstein Journal of Organic Chemistry
The RNA-dependent RNA polymerase (RdRp) represents a prominent target in the discovery and development of new antivirotics against RNA viruses, inhibiting the replication process.
Luca Julianna Tóth   +7 more
doaj   +1 more source

Inhibition of dengue virus replication by novel inhibitors of RNA-dependent RNA polymerase and protease activities [PDF]

open access: yes, 2017
Dengue virus (DENV) is the leading mosquito-transmitted viral infection in the world. With more than 390 million new infections annually, and up to 1 million clinical cases with severe disease manifestations, there continues to be a need to develop new ...
Coluccia, A.   +9 more
core   +1 more source

The use of mycoviruses in the control of forest diseases [PDF]

open access: yes, 2016
Producción CientíficaFifteen families of mycoviruses have been described and 80% of these catalogued. However, their evolutionary relationship with fungi is not clear.
Díez Casero, Julio Javier   +2 more
core   +1 more source

The Paramyxovirus Polymerase Complex as a Target for Next-Generation Anti-Paramyxovirus Therapeutics

open access: yesFrontiers in Microbiology, 2015
The paramyxovirus family includes major human and animal pathogens, including measles virus, mumps virus, and human respiratory syncytial virus (RSV), as well as the emerging zoonotic Hendra and Nipah viruses.
Richard K Plemper, Robert eCox
doaj   +1 more source

Computational mechanisms in genetic regulation by RNA

open access: yes, 2018
The evolution of the genome has led to very sophisticated and complex regulation. Because of the abundance of non-coding RNA (ncRNA) in the cell, different species will promiscuously associate with each other, suggesting collective dynamics similar to ...
Deutsch, J. M.
core   +1 more source

Transgenic resistance to PMTV and PVA provides novel insights to viral long-distance movement [PDF]

open access: yes, 2005
The studies in this thesis describe forms of transgenic resistance to plant viruses and how they can be used for studying viral infection cycle. S. tuberosum cv.
Germundsson, Anna
core  

Home - About - Disclaimer - Privacy